BAESF : Summary for BAE SYSTEMS ORD GBP - Yahoo Finance

U.S. Markets closed

BAE Systems plc (BAESF)


Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
7.65+0.19 (+2.55%)
At close: 1:52PM EST
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close7.46
Open7.66
Bid0.00 x
Ask0.00 x
Day's Range7.50 - 7.66
52 Week Range6.49 - 7.80
Volume3,741
Avg. Volume8,519
Market Cap24.55B
BetaN/A
PE Ratio (TTM)20.90
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • American City Business Journals7 hours ago

    ​BAE Systems buys small partner company on electromagnetic rail gun program

    Arlington-based BAE Systems is acquiring Dayton-based IAP Research Inc., a longtime subcontractor on BAE’s development of an electromagnetic rail gun. Terms of the deal were not disclosed and BAE declined to comment on the size of the company, but a spokesman wrote to me in an email that IAP Research is "not material to BAE Systems’ financials.” With the acquisition, BAE adds about 40 employees. Over the next 12 to 18 months, representatives from BAE Weapons Systems — a part of its much larger Platforms & Services division — and IAP will work on an integration plan that outlines and implements a plan for the combination, a spokesman wrote to me in an email.

  • Benzinga6 days ago

    AQMetrics: Leading RegTech Company Delivering Regulatory And Compliance Solutions

    It's almost that time of year. The 2017 Benzinga Global Fintech Awards is a competition to showcase the companies with the most impressive technology that are paving the future in financial services and ...

  • Reuters8 days ago

    PRESS DIGEST- Financial Times - Feb 14

    Venezuela's vice president labelled international drug trafficker by U.S. GlaxoSmithKline Plc said its new HIV treatment would be "less harmful" than current therapies, as it unveiled clinical trial results for a two-drug cocktail designed to reduce the amount of medicine that patients must take each day. Glencore Plc announced a $960 million deal to buy Israeli billionaire Dan Gertler out of two of the mining-cum-trading company's copper and cobalt operations in the Democratic Republic of Congo.